https://www.selleckchem.com/pr....oducts/cerivastatin-
Multivariate analysis demonstrated AP-related hospitalizations with AKI were 1.97 (CI 1.27-3.08, P 0.001) times more likely to be associated with in-hospital mortality and contributed to 4.3 additional days of hospitalization (CI 4.02-4.6, P 0.001), also incurring an additional $51,830 (CI 48571-55088, P 0.001) in hospital charges. The prevalence of AKI is increasing steadily among pediatric patients with AP and is associated with increased risk of mortality and higher health care resource expenditure. The pre
Like
Comment
Share
